Metastatic prostate cancer in a transgenic mouse

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4096-4102

  Gingrich, Jeffrey R ^a   Barrios, Roberto J ^a   Morton, Ronald A ^a   Boyce, Brendan F ^c   DeMayo, Francesco J ^a   Finegold, Milton J ^b   Angelopoulou, Roxani ^d   Rosen, Jeffrey M ^a   Greenberg, Norman M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c University of Texas Health Sciences ^*  (United States)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TRANSGENE; TRANSGENIC MOUSE;

ADENOCARCINOMA; AGING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, VIRAL, TUMOR; CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NEOPLASM METASTASIS; ORGAN SPECIFICITY; PROSTATIC NEOPLASMS; RECOMBINATION, GENETIC; TIME FACTORS;

EID: 0029832290     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parker, S. L., Tong, T., Bolden, S , and Wingo, P. A. Cancer statistics 1996. CA Cancer J Clin , 46: 5-27, 1996.
2. Ohori, M., Wheeler, T M , Kattan, M. W , Goto, Y , and Scardino, P. T. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol., 154: 1818-1824, 1995.
3. Adams, J. M., and Cory, S. Transgenic models of tumor development. Science (Washington DC), 254: 1161-1167, 1991.
4. Greenberg, N. M , DeMayo, F. J., Sheppard, P. C , Barrios, R., Lebovitz, R., Finegold, M., Angelopoulou, R., Dodd, J. G., Duckworth, M. L., Rosen, J. M., and Matusik, R. J. The rat probasin gene promoter directs hormonally- and developmentally-regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol., 8: 230-239, 1994.
5. Rennie, P. S , Bruchovsky, N., Leco, K. J., Sheppard, P. C., McQueen, S. A., Cheng, H., Snoek, R , Hamel, A., Bock, M. E , MacDonald, B. S., Nickel, B. E., Chang, C., Liao, S., Cattini, P. A., and Matusik, R. J. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol. Endocrinol., 7: 23-36, 1993.
6. Greenberg, N. M., DeMayo, F., Finegold, M J., Medina, D., Tilley, W D , Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., and Rosen, J. M. Prostate cancer in a transgenic mouse Proc. Natl. Acad. Sci. USA, 92: 3439-3443, 1995.
7. Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F., Schaafsma, H. E., Debruyne, F. M., and Isaacs, W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52: 5104-5109, 1992
8. Umbas, R , Isaacs, W. B., Bringuier, P. P., Schaafsma, H. E., Karthaus, H. F., Oosterhof, G O., Debruyne, F. M., and Schalken, J. A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929-3933, 1994
9. Maroulakou, I. G., Anver, M., Garrett, L., and Green, J. E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl. Acad. Sci. USA, 91: 11236-11240, 1994.
10. Qian, J. Q., Bostwick, D. G , Takahashi, S , Borell, T. J., Herath, J. F., Lieber, M M , and Jenkins, R B. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res , 55: 5408-5414, 1995.
11. Bussemakers, M. J , van Moorselaar, R. J., Giroldi, L. A., Ichikawa, T , Isaacs, J T., Takeichi, M., Debruyne, F. M., and Schalken, J. A. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res., 52: 2916-2922, 1992.
12. Mareel, M. M , Behrens, J., Birchmeier, W , De Bruyne, G. K., Vleminckx, K , Hoogewijs, A., Fiers, W. C., and Van Roy, F. M. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int. J. Cancer, 47: 922-928, 1991.
13. Bubendorf, L., Sauter, G., Moch, H., Schmid, H. P., Gasser, T C., Jordan, P., and Mihatsch, M. J KI67 labelling index: an independent predictor of progression in prostate cancer treated by prostatectomy. J. Pathol., 178: 437-441, 1996.
14. Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., and Nelson, W. G Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad Sci. USA, 91: 11733-11737, 1994.
15. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., and Baylin, S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55: 5195-5199, 1995.
16. Morton, R. A., Gingrich, J. R., Foster, B. A., Madewell, L , and Greenberg, N M. E-cadhenn expression in a transgenic animal model of metastatic prostate cancer. J. Urol., 155, 514A, 1996.
17. Lee, C., Shevrin, D. H., and Kozlowski, J. M. In vivo and in vitro approaches to study metastasis in human prostatic cancer. Cancer Metastasis Rev , 12: 21-28, 1993.
18. Stephenson, R A., Dinney, C. P., Gohji, K., Ordonez, N. G., Killion, J. J., and Fidler, I. J Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst., 84: 951-957, 1992.
19. Thalmann, G N., Anezinis, P. E., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res., 54. 2577-2581, 1994.
20. Thompson, T. C., Park, S. H., Timme, T. L., Ren, C , Eastham, J. A., Donehower, L. A., Bradley, A., Kadmon, D , and Yang, G. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. Oncogene, 10: 869-879, 1995.